National Institute for Health Research
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
The National Institute for Health and Care Research (NIHR) is the largest funder of health and social care research in the United Kingdom, primarily funded by the Department of Health and Social Care. Contrary to being a biotechnology company, NIHR operates as a government-backed strategic organization dedicated to improving the health and wealth of the nation through research. Its core mission is to fund high-quality, impactful research that translates into tangible benefits for patients, the public, and the healthcare system, rather than making equity investments as a venture capital firm.
Investor Profile
National Institute for Health Research has backed more than 20 startups, with 3 new investments in the last 12 months alone. The firm has led 14 rounds, about 70% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Pre Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, Canada, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 2 rounds in the past year.
- Typical check size: $63.5K – $6.3M.
Stage Focus
- Grant (90%)
- Pre Seed (5%)
- Series Unknown (5%)
Country Focus
- United Kingdom (80%)
- Canada (10%)
- United States (10%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Therapeutics
- Life Science
- Pharmaceutical
- Health Diagnostics
- Information Services
- Non Profit
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
